 Connection
Christopher Silliman to Blood Substitutes
This is a "connection" page, showing publications Christopher Silliman has written about Blood Substitutes.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.087 |
|
|
|
-
Morton AP, Moore EE, Moore HB, Gonzalez E, Chapman MP, Peltz E, Banerjee A, Silliman C. Hemoglobin-based oxygen carriers promote systemic hyperfibrinolysis that is both dependent and independent of plasmin. J Surg Res. 2017 06 01; 213:166-170.
Score: 0.487
-
Sheppard FR, Moore EE, Johnson JL, Cheng AM, McLaughlin N, Silliman CC. Transfusion-induced leukocyte IL-8 gene expression is avoided by the use of human polymerized hemoglobin. J Trauma. 2004 Oct; 57(4):720-4; discussion 724-5.
Score: 0.234
-
Johnson JL, Moore EE, Offner PJ, Partrick DA, Tamura DY, Zallen G, Silliman CC. Resuscitation with a blood substitute abrogates pathologic postinjury neutrophil cytotoxic function. J Trauma. 2001 Mar; 50(3):449-55; discussion 456.
Score: 0.183
-
Lo KK, Bey EA, Patra B, Benson DD, Boothman DA, Silliman CC, Barnett CC. Hemoglobin-based oxygen carrier mitigates transfusion-mediated pancreas cancer progression. Ann Surg Oncol. 2013 Jun; 20(6):2073-7.
Score: 0.104
-
Roach JP, Moore EE, Partrick DA, Damle SS, Silliman CC, McIntyre RC, Banerjee A. Heme oxygenase-1 induction in macrophages by a hemoglobin-based oxygen carrier reduces endotoxin-stimulated cytokine secretion. Shock. 2009 Mar; 31(3):251-7.
Score: 0.079
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|